Department of Radiology and Imaging Sciences, Indiana University School of Medicine, 550 University Blvd, Rm 06.3, Indianapolis, IN 46202-5253, USA.
AJR Am J Roentgenol. 2013 Jun;200(6):W646-53. doi: 10.2214/AJR.12.8577.
Schwannomas are typically benign tumors that occur sporadically, in neurofibromatosis type 2 (NF2), or in an entity called "schwannomatosis." Schwannomatosis patients develop multiple schwannomas without involvement of the vestibular apparatus. Geneticists, neurologists, and pathologists have recognized that schwannomatosis is distinct from NF2, but schwannomatosis remains unfamiliar to many radiologists. This article reviews the current medical literature, highlighting the similarities and differences between the schwannomatosis and NF2 phenotypes, genotypes, clinical manifestations, management considerations, and imaging findings.
Imaging plays a critical role in diagnosing schwannomatosis, and a basic understanding of this syndrome is of interest to diagnostic radiologists. Moreover, it is imperative that radiologists be able to differentiate schwannomatosis from NF2 on imaging because there are significant differences in the management of these two diseases and clinical outcomes for affected patients.
施万细胞瘤通常为良性肿瘤,其可散发性发生,也可发生于神经纤维瘤病 2 型(NF2)或称为“施万细胞瘤病”的疾病中。施万细胞瘤病患者会发生多个施万细胞瘤,而不累及前庭器官。遗传学家、神经学家和病理学家已经认识到施万细胞瘤病有别于 NF2,但许多放射科医生对此仍不熟悉。本文回顾了当前的医学文献,重点阐述了施万细胞瘤病和 NF2 表型、基因型、临床表现、治疗注意事项和影像学表现之间的异同。
影像学在诊断施万细胞瘤病中发挥着关键作用,因此放射科医生对这种综合征应有基本的了解。此外,放射科医生必须能够在影像学上区分施万细胞瘤病和 NF2,因为这两种疾病的治疗存在显著差异,且对受影响患者的临床转归也有重要影响。